At AMCP Nexus 2026, Susan M. Wescott, RPh, MBA, discussed how health plans evaluate rare disease therapies amid limited data and high costs.
Susan M. Wescott, RPh, MBA
Advertisement
Susan M. Wescott, RPh, MBA, is the senior director of managed care pharmacy at Mayo Clinic.
Articles by Susan M. Wescott, RPh, MBA
Advertisement
Latest Updated Articles
Advertisement
Advertisement
Trending on AJMC
1
At the Pharmacy, Affordability Connects Policy, Plans, and Patients
2
Olanzapine/Samidorphan Tied to Longer Persistence in Schizophrenia
3
UAB Works to Deliver Cutting-Edge Cancer Therapies, Reach Every Patient
4
The DTC GLP-1 Boom Solved Access. Can It Solve Adherence?
5